After Blood Clots, Monitor the Optic Nerve

Papilledema can develop or progress weeks to months later.

Treat-and-extend Wins Again

Patients needed at least a mean of 5.4 fewer injections than those using a monthly regimen.

The Pressure is On

A young patient’s eyes might explain his headaches.

Crisis Management

When a patient with end-stage kidney disease develops visual symptoms, you may have an emergency on your hands.

OCT Reveals At-risk Metamorphopsia Patients

In those with epiretinal membrane, a particular presentation is associated with the visual distortion.

Anti-VEGF Injections Could Lead To RPE Atrophy

In patients with polypoidal choroidal vasculopathy, treatment could have a deleterious side effect.

Long-term Anti-VEGF Use Threatens Optic Nerve

The more injections an AMD patient has, the higher their risk of developing ischemic optic neuropathy.

Retinal Tear Repair Varies Based on Day of the Week

Patients treated on Sundays generally needed a second surgery within 30 days

CNV: Is a Loading Dose Unnecessary?

PRN was just as effective as more intensive anti-VEGF treatment.

Vessel Density Linked to AMD Pathogenesis

Eyes with the exudative form had smaller retinal vessel densities that remained unaffected by anti-VEGF.

Upcoming Events

February 14-17, 2020

Annual Winter Ophthalmic Conference
Location: The Westin Snowmass Conference Center
Program Chairs: Murray Fingeret, OD, FAAO, and Leo Semes, OD, FACMO, FAAO
Up to 17 CE Credits (COPE approval pending)

Register here

April 16-18, 2020

New Technologies & Treatments in Eye Care—Austin
Location: Omni Barton Creek
Program Chair: Paul Karpecki, OD, FAAO
Up to 19 CE Credits (COPE approval pending)

Register here

April 18-19, 2020

Optometric Cornea, Cataract and Refractive Society—Austin
Location: Omni Barton Creek
Program Chair: Tracy Schroeder Swartz, OD, MS, FAAO
Up to 10 CE Credits (COPE approval pending)

Register here


Jobs Powered By Local Eye Site